Rocket Doctor Partners with Remmie to Bring FDA Approved and Health Canada Cleared Smart Otoscope to Patients

Executive Summary

• Rocket Doctor AI Inc. announced a reseller agreement with Remmie, Inc. to distribute the FDA‑ and Health Canada‑cleared Remmie 4 USB‑smart otoscope in Canada.
• Patients purchasing through Rocket Doctor will receive a 20% discount via unique codes, and each device will be co‑branded with Rocket Doctor packaging.
• The collaboration expands Rocket Doctor’s connected‑device ecosystem, supporting virtual care for its >300 MDs and >700,000 patients, with future U.S. rollout under discussion.

Key Details

• Agreement Scope: Reseller agreement (MOU signed 12 Sept 2025) granting Rocket Doctor rights to distribute Remmie 4 devices across Canada; both parties may amend or terminate the MOU upon written notice.
• Product: Remmie 4 – FDA‑registered and Health Canada MDEL‑cleared USB‑smart otoscope for at‑home ear, mouth, and nose exams; integrates with Remmie App/AI and Rocket Doctor platform.
• Discount Structure: 20% discount to customers using unique Rocket Doctor discount codes; discounts tracked via these codes.
• Co‑branding: Devices will feature Rocket Doctor packaging stickers while retaining Remmie branding.
• Operational Impact: Enhances virtual diagnostic capability, reduces unnecessary clinic visits, and improves efficiency of telehealth assessments.
• Patient Reach: Rocket Doctor currently serves >300 MDs and >700,000 patient visits in Canada; the partnership aims to broaden access for families nationwide.
• Future Plans: Ongoing discussions to extend the Remmie 4 program to U.S. patients, leveraging the same discount/co‑branding model.

Notable Quotes

• “Our mission at Remmie has always been to make ear health simple, accessible, and effective,” – Jane Zhang, Founder & CEO, Remmie, Inc.
• “Rocket Doctor is committed to transforming healthcare delivery by connecting patients with technology that makes care more accessible and efficient,” – Dr. William Cherniak, CEO, Rocket Doctor Inc.